Sinovac Biotech Stock Insider Trading

$6.47

+0 (+0%)

At Close: Feb 07, 2020

Date	Action	Amount	Person	Type
Nov 04, 2003	Sell	6 027 870	Ifg Investments Services Inc	Common Shares
Sep 24, 2003	Sell	6 027 870	Ifg Investments Services Inc	Common Shares
Sep 24, 2003	Buy	0	Weidong Yin	Common Shares
Sep 24, 2003	Buy	0	Wang Lily	Common Shares
Sep 24, 2003	Sell	500 000	Bowering Terry G	Common Shares
Nov 01, 2002	Buy	0	Bowering Terry G

JSON CSV

INSIDER POWER
0
Last 6 transactions
Buy: 0 \| Sell: 12 555 740 (Shares)

Based on the 6 latest insides trades, we have calculated the insider power to be negative at a ratio of 0.000.

In total, the insiders bought 0 and sold 12 555 740 SVA shares in the last 6 trades.

About Sinovac Biotech

Sinovac Biotech Ltd., a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of vaccines against hepatitis A, hepatitis B, seasonal influenza, H5N1 and H1N1 pandemic influenza, and mumps in the People's Republic of China. Its marketed products include Healive, an inactivated hepatitis A vaccine; Bilive, a combined inactivated hepatitis A and B vaccine; Anflu, a split viron influenza vaccine; Panflu, ... SVA Profile

Golden Star

Ticker	Date	Change	Price
ETSY	Apr 26	1.84%	$67.43
DHT	Apr 24	1.24%	$11.28
LPLA	Apr 19	2.49%	$262.59
MLI	Apr 19	6.77%	$52.28
PFLT	Apr 18	1.07%	$11.25
DOOR	Apr 18	0.88%	$131.39
LNG	Apr 17	0.644%	$156.81
FCN	Apr 16	2.99%	$207.62
ELV	Apr 16	4.26%	$506.97
ITCI	Apr 05	4.92%	$68.44

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In

Sinovac Biotech Stock Insider Trading

About Sinovac Biotech

Golden Star

Top Fintech Company